论文部分内容阅读
目的 :探讨瘢痕子宫剖宫产产后出血的药物预防治疗体会。方法 :选取2014年1月~2014年9月在我院接受治疗的瘢痕子宫剖宫产患者90例,按照随机的方法将所有的患者分为观察组和对照组各45例,观察组患者给予卡前列甲酯栓联合缩宫素治疗,对照组患者单纯给予缩宫素治疗,比较两组患者治疗后不同时间段出血量。治疗后并发症发生率以及收缩压、舒张压以及脉搏变化情况。结果 :治疗前后,两组患者的收缩压、舒张压以及脉搏情况进行比较,差异无统计学意义;治疗后,观察组患者出现恶心呕吐、胸闷、头晕、腹泻以及窦性心动过速(2.22%、4.44%、0.00%、2.22%、6.67%)等不良反应低于对照组(20.00^%、22.22%、17.78%、22.22%、26.67%、),两组患者进行比较,差异具有统计学意义;观察组患者术中出血量、产后2小时出血量以及产后24小时出血量低于对照组患者,两组患者进行比较,差异具有统计学意义。结论 :卡前列甲酯栓联缩宫素对于预防瘢痕子宫剖宫产产后出血患者效果显著,促进患者的子宫收缩,值得临床推广使用。
Objective: To explore the prevention and treatment of postpartum hemorrhage caused by cesarean section scar. Methods: From January 2014 to September 2014, 90 patients with cesarean scar treated in our hospital were randomly divided into observation group (45 cases) and control group (45 cases). Patients in observation group Cardioprotection with methylester suppository combined with oxytocin treatment, patients in the control group were treated with oxytocin alone, and the bleeding volume was compared between the two groups after treatment. The incidence of postoperative complications and systolic blood pressure, diastolic blood pressure and pulse changes. Results: Before and after treatment, systolic blood pressure, diastolic blood pressure and pulse rate were compared between the two groups. There was no significant difference between the two groups. After treatment, the patients in the observation group showed nausea and vomiting, chest tightness, dizziness, diarrhea and sinus tachycardia (2.22% , 4.44%, 0.00%, 2.22% and 6.67%, respectively) were lower than those in the control group (20.00%, 22.22%, 17.78%, 22.22% and 26.67%, respectively). There was significant difference between the two groups ; The observation group patients intraoperative blood loss, 2 hours postpartum hemorrhage and 24 hours postpartum hemorrhage was lower than the control group patients, the two groups were compared, the difference was statistically significant. Conclusion: Cardiotaxine combined with oxytocin is effective in preventing cesarean section postpartum hemorrhage in patients with cicatricial uterine scar and promoting uterine contractions in patients with cesarean scar. It is worthy of clinical promotion.